We are live on ! Find out more
RXST icon

RxSight
RXST

58 hedge funds and large institutions have $121M invested in RxSight in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,846% more call options, than puts

Call options by funds: $253K | Put options by funds: $13K

92% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 13

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

28% more capital invested

Capital invested by funds: $94.9M → $121M (+$26.4M)

9% more funds holding

Funds holding: 53 → 58 (+5)

1.7% more ownership

Funds ownership: 32.97% → 34.68% (+1.7%)

Holders
58
Holders Change
+5
Holders Change %
+9.43%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
13
Closed
6
Calls
$253K
Puts
$13K
Net Calls
+$240K
Net Calls Change
+$240K

Top Buyers

Rank Fund Capital Flow
1
NCGI
Next Century Growth Investors
Minnesota
+$7.88M
2
MF
Magnetar Financial
Illinois
+$618K
3
ACM
Altium Capital Management
New York
+$615K
4
SSA
Schonfeld Strategic Advisors
New York
+$581K
5
BlackRock
BlackRock
New York
+$487K

Top Sellers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
-$2.66M
2
SC
Sessa Capital
New York
-$1.63M
3
Millennium Management
Millennium Management
New York
-$1.1M
4
Citadel Advisors
Citadel Advisors
Florida
-$188K
5
SC
Saturna Capital
Washington
-$173K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$38.7M – – –
O
2
OrbiMed
New York
$15.2M – – –
BlackRock
3
BlackRock
New York
$13M +$487K +40,036 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.1M -$78.9K -6,484 -0.8%
NCGI
5
Next Century Growth Investors
Minnesota
$8.21M +$7.88M +648,095 New
Millennium Management
6
Millennium Management
New York
$5M -$1.1M -90,723 -19%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$3.86M +$308K +25,322 +9%
CAM
8
Cresset Asset Management
Illinois
$3.84M – – –
State Street
9
State Street
Massachusetts
$3.73M +$37K +3,045 +1%
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$3.27M +$244K +20,059 +8%
PHP
11
Parkman Healthcare Partners
Connecticut
$2.24M +$117K +9,660 +6%
MF
12
Magnetar Financial
Illinois
$2.16M +$618K +50,820 +43%
Northern Trust
13
Northern Trust
Illinois
$1.97M +$65K +5,344 +4%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$878K +$148K +12,208 +21%
N
15
Nuveen
North Carolina
$810K -$43.6K -3,587 -5%
BFS
16
Bradley Foster & Sargent
Connecticut
$729K +$2.13K +175 +0.3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$719K -$1.65K -136 -0.2%
Charles Schwab
18
Charles Schwab
California
$675K +$14.8K +1,214 +2%
ACM
19
Altium Capital Management
New York
$641K +$615K +50,586 New
SSA
20
Schonfeld Strategic Advisors
New York
$606K +$581K +47,800 New
Bank of America
21
Bank of America
North Carolina
$525K +$82.5K +6,781 +20%
IWM
22
IHT Wealth Management
Illinois
$440K -$91.2K -7,500 -18%
LPL Financial
23
LPL Financial
California
$406K +$390K +32,058 New
BFM
24
Boothbay Fund Management
New York
$386K +$67K +5,505 +22%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$328K +$6.9K +567 +2%
1
2 3

RXST Hedge Fund Activity: Q4 2022 in Review

58 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2022, worth a combined $121M — up 28% from $94.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RXST positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 13 trimmed.

The largest buyer was Next Century Growth Investors, opening a new position worth an estimated $7.88M. The largest seller was Bridger Management, exiting entirely with an estimated $2.66M sold.

  • 58 institutional investors held RxSight (RXST) as of Q4 2022, up from 53 in Q3 2022.
  • Funds reported $121M of RxSight stock for Q4 2022, up 28% quarter-over-quarter.
  • 11 funds opened new RxSight positions in Q4 2022 and 6 closed out, a net change of +5 holders.
  • The largest RxSight buyer in Q4 2022 was Next Century Growth Investors, an estimated $7.88M added.
  • The largest RxSight seller in Q4 2022 was Bridger Management, an estimated $2.66M sold.

Based on aggregated 13F filings for Q4 2022.